Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1528 EUR
−3.17 M EUR
10.06 K EUR
57.44 M
About QUANTUM GENOMICS
Sector
CEO
Jean-Philippe Milon
Headquarters
Paris
Website
Founded
2005
ISIN
FR0011648971
FIGI
BBG00JWMXS15
Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. It focuses on the development of drug class based on the central action mechanism of Aminopeptidase A inhibition. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0D1J is 0.0720 EUR — it has decreased by −44.65% in the past 24 hours. Watch QUANTUM GENOMICS EUR0.040 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange QUANTUM GENOMICS EUR0.040 stocks are traded under the ticker 0D1J.
0D1J reached its all-time high on Sep 2, 2021 with the price of 5.8406 EUR, and its all-time low was 0.0720 EUR and was reached on Oct 17, 2024. View more price dynamics on 0D1J chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0D1J stock is 80.66% volatile and has beta coefficient of 4.92. Track QUANTUM GENOMICS EUR0.040 stock price on the chart and check out the list of the most volatile stocks — is QUANTUM GENOMICS EUR0.040 there?
Today QUANTUM GENOMICS EUR0.040 has the market capitalization of 5.00 M, it has decreased by −4.01% over the last week.
Yes, you can track QUANTUM GENOMICS EUR0.040 financials in yearly and quarterly reports right on TradingView.
QUANTUM GENOMICS EUR0.040 is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
0D1J net income for the last half-year is −8.22 M EUR, while the previous report showed −1.19 M EUR of net income which accounts for −593.10% change. Track more QUANTUM GENOMICS EUR0.040 financial stats to get the full picture.
No, 0D1J doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QUANTUM GENOMICS EUR0.040 EBITDA is −2.27 M EUR, and current EBITDA margin is −31.26 K%. See more stats in QUANTUM GENOMICS EUR0.040 financial statements.
Like other stocks, 0D1J shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QUANTUM GENOMICS EUR0.040 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QUANTUM GENOMICS EUR0.040 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QUANTUM GENOMICS EUR0.040 stock shows the strong sell signal. See more of QUANTUM GENOMICS EUR0.040 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.